Læknablaðið - 15.01.1994, Blaðsíða 37

LÆKNABLAÐIÐ 1994; 80: 25-27
27
markers and the detection of Down’s syndrome.
London: RCOG, 1993.
3. Aitken DA, Crossley JA. Screening for chromosome
abnormalities. Current Obstet Gynaecol 1992; 2: 65-71.
4. Benacerraff BR. Prenatal sonography of autosomal
trisomies. Ultrasound Obstet Gynecol 1991; 2: 66-75.
5. McKusick VA. Mendelian inheritance in man,
eight edition. Baltimore and London: John Hopkins
University Press. 1988.
6. King’s Fund forum consensus statement: screening
for fetal and genetic abnormalitiy. Br Med J. 1987:
295: 1551-3.
7. Merkatz 1R, Nitowsky HM, Macri JN, Johnsom WE.
An association between low matemal serum alpha-
fetoprotein and fetal chromosomal abnormalities. Am
J Obstet Gynecol 1984; 148: 886-94.
8. Aitken D. Maternal serum screening for fetal
chromosome abnormalities and neural tube defects
in the first trimester. Clinical Cytogenetics Bulletin
1993; 2: 91-102.
9. Macintosh MCM, Chard T. First trimester
biochemical screening for Down's syndrome.
Contemp Rev Obstet Gynecol 1992; 4: 185-90.
10. Wald N, Cuckle HS, Densem JW, Kennard A, Smith
D. Matemal serum screening for Down’s syndrome:
the effect of routine ultrasound scan determination og
gestational age and adjustment for maternal weight.
Brit J Obstet Gynaecol 1992; 99: 144-9.
11. Hreiðarsson SJ, Jóhannsson JH, Kjeld M. Alfa-
fetoprótín í sermi þungaðra kvcnna og tengsl þess
við litningagalla (þrístæðu 21) hjá fóstri. Læknablaðið
1993; 79: 135-40.